Lexicon Pharmaceuticals
LXRX
$1.58
Share price
-0.04%
Change (1 day)
-33.92%
Change (1 year)
Categories
Lexicon Pharmaceuticals (LXRX) - Net assets
Net assets on the balance sheet as of December 2023 : $93.11 M
According to Lexicon Pharmaceuticals
's latest financial reports the company has $93.11 M in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Lexicon Pharmaceuticals - Net assets on balance sheet (from 2001 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $0.11 B | 3.11% |
| 2021-12-31 | $0.11 B | -27.36% |
| 2020-12-31 | $0.15 B | 33.54% |
| 2019-12-31 | $0.11 B | -543.48% |
| 2018-12-31 | $-26.41 M | -138.68% |
| 2017-12-31 | $68.26 M | -56.63% |
| 2016-12-31 | $0.15 B | -44.94% |
| 2015-12-31 | $0.28 B | 0.65% |
| 2014-12-31 | $0.28 B | 66.91% |
| 2013-12-31 | $0.17 B | -36.19% |
| 2012-12-31 | $0.26 B | -10.38% |
| 2011-12-31 | $0.29 B | 20.46% |
| 2010-12-31 | $0.24 B | 51.09% |
| 2009-12-31 | $0.16 B | -16.51% |
| 2008-12-31 | $0.19 B | -31.67% |
| 2007-12-31 | $0.28 B | 235.17% |
| 2006-12-31 | $85.5 M | -0.35% |
| 2005-12-31 | $85.8 M | -29.44% |
| 2004-12-31 | $0.12 B | -26.85% |
| 2003-12-31 | $0.16 B | -2.17% |
| 2002-12-31 | $0.16 B | -22.2% |
| 2001-12-31 | $0.21 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | $46.84 B | 50,208.24% | 🇺🇸 USA |
 Illumina ILMN | $5.74 B | 6,070.12% | 🇺🇸 USA |
 Regeneron Pharmaceuticals REGN | $25.97 B | 27,795.07% | 🇺🇸 USA |
 Ultragenyx RARE | $0.27 B | 195.79% | 🇺🇸 USA |
 Ligand Pharmaceuticals LGND | $0.70 B | 652.78% | 🇺🇸 USA |
 Esperion Therapeutics ESPR | -$0.46 B | -588.66% | 🇺🇸 USA |
 Aerie Pharmaceuticals AERI | -$0.17 B | -276.12% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $4.95 B | 5,217.96% | 🇺🇸 USA |
 Eterna Therapeutics ERNA | $2.23 M | -97.60% | 🇺🇸 USA |